2 Beaten-Down Biotech Stocks That Could Be Great Long-Term Plays

Sometimes in life, it pays to go against the tide. That's also true in the stock market. Forgotten companies -- or those whose shares have gotten hammered -- can turn out to be excellent investment opportunities. After all, there's no better time to invest in a quality stock than when it's lost serious altitude.

With that in mind, let's look at two healthcare stocks that have performed poorly over the past year but have a chance to bounce back big: Gilead Sciences (NASDAQ: GILD) and Incyte (NASDAQ: INCY). 

Continue reading

Source Fool.com